MO01.29 Randomized, Open-Label Study of Bintrafusp Alfa vs. Pembrolizumab as First-Line (1L) Treatment in Patients with PD-L1–Expressing Advanced Non-Small Cell Lung Cancer (NSCLC)
| Autor: | Ahn, M.-J., Barlesi, F., Felip, E., Garon, E., Martin, C.M., Vokes, E., Koenig, A., Dussault, I., Ojalvo, L.S., Paz-Ares, L. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology January 2021 16(1) Supplement:S27-S28 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|